Sievert W - Search Results

1

Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.

Hall SAL, Burns GS, Anagnostou D, Vogrin S, Sundararajan V, Ratnam D, Levy MT, Lubel JS, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Angus P, Sinclair M, Meredith C, Matthews G, Revill PA, Jackson K, Littlejohn M, Bowden DS, Locarnini SA, Visvanathan K, Thompson AJ. Hall SAL, et al. Among authors: sievert w. Aliment Pharmacol Ther. 2022 Jul;56(2):310-320. doi: 10.1111/apt.16968. Epub 2022 May 6. Aliment Pharmacol Ther. 2022. PMID: 35521992

2

Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection.

Pianko S, Patella S, Ostapowicz G, Desmond P, Sievert W. Pianko S, et al. Among authors: sievert w. J Viral Hepat. 2001 Nov;8(6):406-13. doi: 10.1046/j.1365-2893.2001.00316.x. J Viral Hepat. 2001. PMID: 11703571

3

Serum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections.

Kelly HA, Maskill WJ, Sievert W, Bowden DS. Kelly HA, et al. Among authors: sievert w. Med J Aust. 2002 Feb 4;176(3):139. doi: 10.5694/j.1326-5377.2002.tb04333.x. Med J Aust. 2002. PMID: 11936320 No abstract available.

4

Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection.

Danta M, Dore GJ, Hennessy L, Li Y, Vickers CR, Harley H, Ngu M, Reed W, Desmond PV, Sievert W, Farrell GC, Kaldor JM, Batey RG. Danta M, et al. Among authors: sievert w. Med J Aust. 2002 Sep 2;177(5):240-5. doi: 10.5694/j.1326-5377.2002.tb04755.x. Med J Aust. 2002. PMID: 12197817

5

Induction interferon and ribavirin for re-treatment of chronic hepatitis C patients unresponsive to interferon alone.

Sievert W, Batey R, Mollison L, Pianko S, McDonald J, Marinos G, Reed W, Warner S, Bowden S, De Solom R, Bhathal P; AusHep Investigators. Sievert W, et al. Aliment Pharmacol Ther. 2003 May 1;17(9):1197-204. doi: 10.1046/j.1365-2036.2003.01544.x. Aliment Pharmacol Ther. 2003. PMID: 12752357 Clinical Trial.

6

Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B.

Lim SG, Marcellin P, Tassopoulos N, Hadziyannis S, Chang TT, Tong M, Sievert W, Hu P, Arterburn S, Brosgart CL; International Investigator Groups for Studies 437 and 438. Lim SG, et al. Among authors: sievert w. Aliment Pharmacol Ther. 2007 Nov 15;26(10):1419-28. doi: 10.1111/j.1365-2036.2007.03506.x. Aliment Pharmacol Ther. 2007. PMID: 17983369 Clinical Trial.

7

Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.

Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW. Lubel JS, et al. Among authors: sievert w. Clin Sci (Lond). 2009 Sep 14;117(11):375-86. doi: 10.1042/CS20080647. Clin Sci (Lond). 2009. PMID: 19371232

8

Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM; Australian Trial In Acute Hepatitis C Study Group. Dore GJ, et al. Gastroenterology. 2010 Jan;138(1):123-35.e1-2. doi: 10.1053/j.gastro.2009.09.019. Epub 2009 Sep 24. Gastroenterology. 2010. PMID: 19782085 Free PMC article.

9

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.

Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M; ATAHC Study Group. Grebely J, et al. Drug Alcohol Depend. 2010 Mar 1;107(2-3):244-9. doi: 10.1016/j.drugalcdep.2009.09.015. Drug Alcohol Depend. 2010. PMID: 19926405 Free PMC article. Clinical Trial.

10

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, Yeung B, Marks P, Rawlinson W, Lloyd AR, Booth D, Kaldor JM, George J, Dore GJ; ATAHC Study Group. Grebely J, et al. Hepatology. 2010 Oct;52(4):1216-24. doi: 10.1002/hep.23850. Hepatology. 2010. PMID: 20803561 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters